4-Fluoro-2-(trifluoromethyl)benzylamine, 97.0%, 25g

5-isopropyl-2-methoxy-4-methylbenzenesulfonyl chloride, 95.0%, 5g

4-Iodobenzophenone, 98.0%, 1g

N-Methyl-L-alanine, 98.0%, 100g

2,6-Dibromoanthracene, 95.0%, 1g

6,6'-dihydroxy-5,5'-dimethoxybiphenyl-3,3'-dicarbaldehyde, 97%, 1g

BENZYL (3-HYDROXYBENZYL)CARBAMATE, 95.0%, 100mg

E-Plan phase EPLPHi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm

Methyl 5-nitrothiophene-3-carboxylate, 95+%, 500mg

2-Methyl-4-(trifluoromethyl)thiazole-5-carboxylic acid, 95.0%, 5g

(OC-6-21)-Tris[2-(2-pyridinyl-?N)phenyl-?C]iridium, 98%, 100mg

2-Acetyl-5-iodothiophene, 97.0%, 25g

1-[4-AMINO-2-(METHYLTHIO)-5-PYRIMIDINYL]-ETHANONE, 95.0%, 250mg